TherapeuticsMD, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 1.19 M | $1.98 M | 0.00% | 10.34% |
| CLEARLINE CAPITAL LP | 11/14/2024 | 636,622 | $1.06 B | 0.00% | 5.52% |
| TEJARA CAPITAL LTD | 11/13/2024 | 401,446 | $666,400 | -0.12% | 3.48% |
| VANGUARD GROUP INC | 11/13/2024 | 387,582 | $643,386 | 0.00% | 3.36% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 270,160 | $448,466 | 0.00% | 2.34% |
| MORGAN STANLEY | 11/14/2024 | 131,719 | $218,654 | 0.09% | 1.14% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 116,132 | $192,780 | 100.00% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 108,333 | $179,872 | 13.47% | 0.94% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 34,000 | $56,440 | 0.00% | 0.29% |
| STATE STREET CORP | 11/14/2024 | 30,100 | $49,966 | 0.00% | 0.26% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 22,470 | $37,300 | 0.00% | 0.19% |
| J. GOLDMAN & CO LP | 11/14/2024 | 13,562 | $22,513 | 0.00% | 0.12% |
| FMR LLC | 11/13/2024 | 8,289 | $13,760 | 0.00% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 7,100 | $11,786 | 7,000.00% | 0.06% |
| UBS GROUP AG | 11/14/2024 | 4,847 | $8,046 | -46.83% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 4,500 | $7,470 | -51.09% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,270 | $3,768 | -35.77% | 0.02% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 610 | $1,013 | 0.00% | 0.01% |
| CAPITAL PERFORMANCE ADVISORS LLP | 11/01/2024 | 600 | $996 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 494 | $820 | 1.44% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 293 | $486 | 0.00% | 0.00% |
| US BANCORP \DE\ | 10/28/2024 | 246 | $408 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 144 | $239 | -15.79% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 10/28/2024 | 126 | $209 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 11/06/2024 | 120 | $199 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 56 | $92 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 11/12/2024 | 40 | $66 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/04/2024 | 8 | $13 | 0.00% | 0.00% |
| ASSETMARK, INC | 11/01/2024 | 4 | $7 | 100.00% | 0.00% |
| GUARDIAN WEALTH MANAGEMENT, INC. | 11/15/2024 | 2 | $3 | 0.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 11/12/2024 | 1 | $2 | 100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/08/2024 | 1 | $2 | 0.00% | 0.00% |
| ASPIRE PRIVATE CAPITAL, LLC | 10/25/2024 | 1 | $2 | 0.00% | 0.00% |
| GABELLI FUNDS LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
TherapeuticsMD, Inc.institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of TherapeuticsMD, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 1.19 M
Clearline Capital LP: 636,622
Tejara Capital Ltd: 401,446
VANGUARD GROUP INC: 387,582
ADAR1 Capital Management, LLC: 270,160
MORGAN STANLEY: 131,719
29.30% of TherapeuticsMD, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.54 M shares in the last 24 months. This purchase volume represents approximately $3.93 M in transactions.